In brain injuries, the metalloproteinase ADAM17 releases the transforming growth factor alpha (TFGα) which activates the epidermal growth factor receptor (EGFR), thus promoting the creation of a gliogenic/non-neurogenic environment [242]. This evidence concerns the gene EGFR and brain injury.